LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$3.74
-9.56%
Mkt Cap $127.61M
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (7 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+87.4%
Consensus $7.00 vs current $3.74
NASDAQ·Healthcare·Biotechnology
$3.74
-9.56%
Mkt Cap $127.61M
Buy
4
Hold
2
Sell
0
Price Target (7 analysts)
$7.00
Range $7.00 – $7.00
+87.4%
Consensus $7.00 vs current $3.74